Vircell participated in the 10th Congress on Advances Against Aspergillosis and Mucormycosis last week, which brought together a large number of infectious diseases specialists from different countries. More than 90 posters were published and over 30 presentations were given.
The experience enabled us to learn about scientific advances in the sector and interact with world-class experts in the field. The ASPERGILLUS GALACTOMANNAN Ag VIRCLIA® MONOTEST was presented as a reliable and effective diagnostic tool for the diagnosis of invasive aspergillosis.
The event was without a doubt a success, which we hope will be repeated next year.